Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,800 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 October 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 4MB, 241 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 26 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is O  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
M. Ozawa, Brennan, P. M., Zienius, K., Kurian, K. M., Hollingworth, W., Weller, D., Grant, R., Hamilton, W., and Ben-Shlomo, Y., “The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014)”, BMJ Open, vol. 9, p. e029686, 2019.
J. O. Oyinlola, Campbell, J., and Kousoulis, A. A., “Is real world evidence influencing practice? A systematic review of CPRD research in NICE guidances”, BMC Health Serv Res, vol. 16, p. 299, 2016.
F. Othman, Card, T. R., and Crooks, C. J., “Proton pump inhibitor prescribing patterns in the UK: a primary care database study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1079-87, 2016.
F. Othman, Crooks, C. J., and Card, T. R., “Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study”, Bmj, vol. 355, p. i5813, 2016.
H. Otete, Fleming, M. K., West, J., and Orton, E., “Healthcare Utilisation, Morbidities and Alcohol Use Monitoring Prior to Alcoholic Psychosis Diagnosis”, Alcohol Alcohol, 2018.
J. W. O'Sullivan, Stevens, S., Hobbs, F. D. R., Salisbury, C., Little, P., Goldacre, B., Bankhead, C., Aronson, J. K., Perera, R., and Heneghan, C., “Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests”, Bmj, vol. 363, p. k4666, 2018.
J. W. O'Sullivan, Stevens, S., Oke, J., Hobbs, F. D. R., Salisbury, C., Little, P., Goldacre, B., Bankhead, C., Aronson, J. K., Heneghan, C., and Perera, R., “Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16”, BMC Med, vol. 16, p. 229, 2018.
M. T. Osterman, Yang, Y. X., Brensinger, C., Forde, K. A., Lichtenstein, G. R., and Lewis, J. D., “No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease”, Clin Gastroenterol Hepatol, vol. 9, pp. 875-80, 2011.
O. A. Oshagbemi, Burden, A. M., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., Driessen, J. H. M., van der Zee, A. H. Maitlan, de Vries, F., and Franssen, F. M. E., “Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts”, Am J Respir Crit Care Med, vol. 195, pp. 1402-1404, 2017.
O. A. Oshagbemi, Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., van der Zee, A. H. Maitlan, Burden, A. M., and de Vries, F., “Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1191-1199, 2018.
O. A. Oshagbemi, Keene, S. J., Driessen, J. H. M., Jordan, R., Wouters, E. F. M., de Boer, A., de Vries, F., and Franssen, F. M. E., “Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013”, Respir Med, vol. 144, pp. 1-6, 2018.
O. A. Oshagbemi, Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., and de Vries, F., “Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD)”, Copd, pp. 1-8, 2019.
O. A. Oshagbemi, Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., de Boer, A., and de Vries, F., “C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD”, Pulm Pharmacol Ther, p. 101870, 2019.
D. P. Osborn, Levy, G., Nazareth, I., Petersen, I., Islam, A., and King, M. B., “Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database”, Arch Gen Psychiatry, vol. 64, pp. 242-9, 2007.
D. Osborn, Levy, G., Nazareth, I., and King, M., “Suicide and severe mental illnesses. Cohort study within the UK general practice research database”, Schizophr Res, vol. 99, pp. 134-8, 2008.
C. S. Osam, Pierce, M., Hope, H., Ashcroft, D. M., and Abel, K. M., “The influence of maternal mental illness on vaccination uptake in children: a UK population-based cohort study”, Eur J Epidemiol, 2020.
M. A. O'Rorke, Murray, L. J., Hughes, C. M., Cantwell, M. M., and Cardwell, C. R., “The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink”, Cancer Causes Control, vol. 26, pp. 355-66, 2015.
J. D. Orlander, Jick, S. S., Dean, A. D., and Jick, H., “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
L. Opatrny, Delaney, J. A., and Suissa, S., “Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look”, Br J Clin Pharmacol, vol. 66, pp. 76-81, 2008.
H. O'Meara, Carr, D. F., Evely, J., Hobbs, M., McCann, G., Van Staa, T., and Pirmohamed, M., “Electronic health records for biological sample collection: feasibility study of statin-induced myopathy using the Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 77, pp. 831-8, 2014.
M. Olsson, Schnecke, V., Cabrera, C., Skrtic, S., and Lind, M., “Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes”, Diabetes Care, vol. 38, pp. 1481-6, 2015.
J. R. Olsen, Piguet, V., Gallacher, J., and Francis, N. A., “Molluscum contagiosum and associations with atopic eczema in children: a retrospective longitudinal study in primary care”, Br J Gen Pract, vol. 66, pp. e53-8, 2016.
I. Olier, Springate, D. A., Ashcroft, D. M., Doran, T., Reeves, D., Planner, C., Reilly, S., and Kontopantelis, E., “Modelling Conditions and Health Care Processes in Electronic Health Records: An Application to Severe Mental Illness with the Clinical Practice Research Datalink”, PLoS One, vol. 11, p. e0146715, 2016.
O. R. Olaiya and Huynh, M. N. Q., “Dupuytren's Disease Predicts Increased All-Cause and Cancer-Specific Mortality: Analysis of a Large Cohort from the U.K. Clinical Practice Research Datalink”, Plast Reconstr Surg, vol. 147, p. 890e-891e, 2021.
I. A. Odeyemi, Dakin, H. A., O'Donnell, R. A., Warner, J., Jacobs, A., and Dasgupta, P., “Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care”, Int J Clin Pract, vol. 60, pp. 949-58, 2006.
N. E. O'Connell, Smith, K. J., Peterson, M. D., Ryan, N., Liverani, S., Anokye, N., Victor, C., and Ryan, J. M., “Incidence of osteoarthritis, osteoporosis and inflammatory musculoskeletal diseases in adults with cerebral palsy: A population-based cohort study”, Bone, vol. 125, pp. 30-35, 2019.
[Page last reviewed 5 October 2021]